
| Company Name: | Glenmark Pharma Ltd |
| OldName: | |
| Group : | |
| Address: | Corp Office |
| Glenmark House, B D S Marg, |
| Chakala, Off Western Express Highway, Andheri East |
| City: | Mumbai 400099 Mumbai Maharashtra |
| Tel: | 022-4018 9999 |
| Fax: | 022-4018 9990 |
| Mktg-Email : | india_marketing@glenmarkpharma.com |
| HR-Email : | |
| Purchase-Email : | |
| Brands Owned : | |
About the Company :
Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India. It’s subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,400 people in over 80 countries. It has 14 manufacturing facilities in four countries and has 6 R&D centres.
In September 2019, the company has received its board approval to raise $ 200 million through issuance of debt securities
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(76.6%2017%2030.4)%20scale(58.43113%20234.59014)%22%2F%3E%3Cellipse%20fill%3D%22%2361683b%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(74.9%20-18.7%20192.8)%20scale(97.15601%20191.02269)%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(93.4688%20-25.57017%208.04366%2029.40267%2055.4%2011.2)%22%2F%3E%3Cellipse%20fill%3D%22%2384809a%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-175.3%2043%2059.3)%20scale(74.87227%2038.4888)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Glenmark Pharma has received final USFDA approval for its Ranolazine extended-release tablets used for treatment of chronic angina. The drug ...
%22%20transform%3D%22translate(.5%20.5)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23e9a3bd%22%20cx%3D%2267%22%20cy%3D%2279%22%20rx%3D%2263%22%20ry%3D%2230%22%2F%3E%3Cellipse%20fill%3D%22%23ee8eaf%22%20cx%3D%2273%22%20cy%3D%2260%22%20rx%3D%2218%22%20ry%3D%2236%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-7.78192%2031.26033%20-144.58725%20-35.99345%2082.3%205.8)%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(58.3%20-20.3%2026.9)%20scale(46.93348%2031.30658)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Glenmark Pharmaceuticals has received final USFDA approval for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in ...
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-14.50818%20-45.24912%20222.34768%20-71.29113%2091.9%203.5)%22%2F%3E%3Cellipse%20fill%3D%22%2361683b%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(73.1%20-19.8%20192.8)%20scale(90.14089%20198.01461)%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(8.32852%2033.21466%20-96.88911%2024.29478%2053.7%208.3)%22%2F%3E%3Cellipse%20fill%3D%22%2386839a%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-10.37954%2048.03916%20-84.3545%20-18.22598%2071.3%20109.7)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Glenmark has receive final USFDA approval for Solifenacin Succinate Tablets in strengths of 5 mg and 10 mg. The drug ...

Glenmark Pharma has received final USFDA approval to market a generic version of AstraZeneca’s Nexium, used to treat acid reflux ...
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(11.32914%2038.40486%20-247.44645%2072.9948%2037%2029.1)%22%2F%3E%3Cellipse%20fill%3D%22%2361683a%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-23.15398%20-79.18044%20180.90127%20-52.89923%20173.4%20147)%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(84.55824%20-20.31605%207.0991%2029.5474%2049.6%2014)%22%2F%3E%3Cellipse%20fill%3D%22%234d4867%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-89.3%20145%20-57.6)%20scale(31.76435%2084.90743)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of BenzaClin gel used in the treatment of acne ...
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-221.34215%2068.35357%20-12.03906%20-38.98481%2076.9%2014.5)%22%2F%3E%3Cellipse%20fill%3D%22%2361683a%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-176.68558%2056.73396%20-24.40867%20-76.01549%20164.8%20146.4)%22%2F%3E%3Cellipse%20fill%3D%22%23fff%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(94.706%20-26.02204%2011.0891%2040.35823%2056.9%20.5)%22%2F%3E%3Cellipse%20fill%3D%22%2384809a%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(81.59193%209.152%20-4.07655%2036.3433%2075%20120.5)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Glenmark Pharma has received final USFDA approval for Sevelamer Hydrochloride tablets to market the same in US markets. The product ...
| Personnel |
| Glenn Saldanha | – Chairman & Managing Director |
| Cherylann Pinto | – Director – Corporate Affairs |
| J F Ribeiro | – Non Executive Director |
| Sridhar Gorthi | – Non Executive Director |
| Bernard Munos | – Non Executive Director |
| Rajesh Desai | – Executive Director |
| D R Mehta | – Non Executive Director |
| N B Desai | – Non Executive Director |
| Brian W Tempest | – Non Executive Director |
| B E Saldanha | – Non Executive Director |
Other Office Address
| Plant E-37, MIDC Industrial Area, D Road, Satpur Satpur 422007 Nashik Maharashtra Tel: 0253 661 3999 |
| Plant D 42, Plot no. 50, Kundaim Industrial Estate, Kundaim Kundaim 403115 South Goa Goa Tel:0832-6652222 /6652259 Fax: 0832-6652323 |
| Plant Plot No. 7, Colvale Industrial Estate, Bardez Bardez 403513 North Goa Goa Tel: 0832-6652222 /6652259 |
| Plant Plot No. C-152, MIDC Sinnar Industrial Area, Malegaon Malegaon 422113 Nashik Maharashtra Tel: 02551 660 222 |
| Plant Plot No. A-607, TTC Industrial Area, MIDC. Mahape, Vashi Navi Mumbai 400705 Thane Maharashtra Tel: 022 6772 0000 |
| Plant Plot No.A-80, MIDC Area, Kurkumbh, Daund Kurkumbh 413802 Pune Maharashtra Tel: 022 4018 9999 |
| Plant 3109-C, GIDC Industrial Estate, Ankleshwar Ankleshwar 393002 Bharuch Gujarat Tel: 098819 54247 |
| Plant Plot No. 163-165 & 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth Bazarpeth Mohol 413213 Solapur Maharashtra Email: ashok@glenmark.generics.com |
| Plant Unit – III: Village Kishanpura, Baddi Nalagarh Road Gurumajra 174101 Solan Himachal Pradesh |
| Plant Plot No 2, Phase -II, Pharma Zone, Special Economic Zone Area, Pithampur Pithampur 454775 Dhar Madhya Pradesh |
| Plant Growth Centre, Samlik-Marchak Samlik-Marchak Gangtok East Sikkhim Sikkhim |
| Plant Plot No B-25, Five Star MIDC, Shendra Shendra 431201 Aurangabad Aurangabad Maharashtra |
| Corp Office Glenmark House, B D S Marg, Chakala, Off Western Express Highway, Andheri East Mumbai 400099 Mumbai Maharashtra 022-4018 9999 022-4018 9990 |
Leave a Reply